Maximal Use Systemic Exposure (MUSE) Study of Levulan Kerastick

PHASE2CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

December 31, 2014

Primary Completion Date

April 30, 2015

Study Completion Date

April 30, 2015

Conditions

Keratosis, Actinic

Interventions

DRUG

Aminolevulinic Acid (ALA)

20% ALA applied to upper extremities for 3 hours prior to 10 J/cm2 blue light

DEVICE

BLU-U

10 J/cm2 of 417 nm blue light delivered at 10 mW/cm2

Trial Locations (3)

Shideler Clinical Research Center, Carmel

DermResearch, Inc., Austin

Therapeutics Clinical Research, San Diego